Search results
Results from the WOW.Com Content Network
Diversion Investigator (DI) is the title of a specialist position within the Drug Enforcement Administration (DEA) of the United States Department of Justice.DIs are responsible for addressing the problem of diversion of controlled pharmaceuticals and regulated chemicals from the legitimate channels in which they are manufactured, distributed, and dispensed.
"Our DEA Diversion Investigators worked to combat the source of the problem, and the focus shifted to the supply chain, including brokers and distributors operating outside the state of Texas. The ...
Pages in category "Drug Enforcement Administration" The following 26 pages are in this category, out of 26 total. ... DICE (DEA database) Diversion Investigator;
Once the DEA has collected the necessary data, the Administrator of the Drug Enforcement Association, by authority of the Attorney General, requests from the HHS a scientific and medical evaluation and recommendation as to whether the drug or other substance should be controlled or removed from control. This request is sent to the Assistant ...
A New York City pharmacist under investigation by federal drug authorities allegedly took "sinister action" to disrupt the probe: he had a greeting card filled with cocaine sent to the home of the ...
The System to Retrieve Information from Drug Evidence (STRIDE) is a United States Drug Enforcement Administration (DEA) program consisting of six subsystems providing information on drug intelligence, statistics on markings found on pills and capsules, drug inventory, tracking, statistical information on drugs removed from the marketplace, utilization of laboratory manpower and information on ...
The four-year investigation, dubbed “Operation Front Runner,” spanned from October 2019 to October 2023. It began with federal drug agents tracking suspects, some of them Chinese, as they ...
The DEA denied the Petition for Rescheduling on July 8, 2011. [61] [62] [63] In response to the petition's denial, medical cannabis advocacy group Americans for Safe Access appealed to the D.C. Circuit on January 23, 2012. [64] Oral arguments in the case Americans for Safe Access v. DEA were heard on October 16, 2012. [65]